|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Amortization of premiums/discounts on securities, net | |||||
| Gain on sale of loans | |||||
| Microloans (recoveries) write-off | |||||
| Provision for credit losses | |||||
| Depreciation and amortization | |||||
| ESOP compensation expense | |||||
| Share-based compensation expense | |||||
| Deferred income taxes (benefit) | |||||
| Changes in assets and liabilities: | |||||
| Decrease (increase) in mortgage loans held for sale, at fair value | |||||
| Increase (decrease) in accrued interest receivable | |||||
| Decrease (increase) in other assets | |||||
| (Decrease) increase in accrued interest payable | |||||
| Decrease in operating lease liabilities | |||||
| (Decrease) increase in advance payments by borrowers | |||||
| Net (decrease) increase in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Proceeds from redemption of FHLBNY Stock | |||||
| Purchases of FHLBNY Stock | |||||
| Net (purchase) redemption of FHLBNY Stock | |||||
| Purchase of FRBNY stock | |||||
| Purchases of held-to-maturity securities | |||||
| Proceeds from maturities, calls and principal repayments on securities | |||||
| Placements with banks | |||||
| Proceeds from sales of loans | |||||
| Net increase in loans | |||||
| Purchase of loans | |||||
| Purchases of premises and equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities: | |||||
| Net increase in deposits | |||||
| Stock options exercised | |||||
| Repurchase of treasury stock | |||||
| Dividends paid on preferred stock | |||||
| Net (repayments) proceeds from borrowings | |||||
| Net cash provided by financing activities | |||||
| Net decrease (increase) in cash and cash equivalents | |||||
| Cash and Cash Equivalents, including restricted cash: | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest | |||||
| Income taxes | |||||
| Supplemental Disclosures of Noncash Investing Activities: | |||||
| Loans receivable | |||||
Loading...